Literature DB >> 30377193

Participation and yield of a population-based colorectal cancer screening programme in China.

Hongda Chen1, Ni Li1, Jiansong Ren1, Xiaoshuang Feng1, Zhangyan Lyu1, Luopei Wei1, Xin Li1, Lanwei Guo1, Zhaoxu Zheng2, Shuangmei Zou3, Yueming Zhang4, Jiang Li1, Kai Zhang5, Wanqing Chen1, Min Dai1, Jie He6.   

Abstract

OBJECTIVE: Colorectal cancer (CRC) screening has been widely implemented in many countries. However, evidence on participation and diagnostic yield of population-based CRC screening in China is sparse.
DESIGN: The analyses were conducted in the context of the Cancer Screening Program in Urban China, which recruited 1 381 561 eligible participants aged 40-69 years from 16 provinces in China from 2012 to 2015. 182 927 participants were evaluated to be high risk for CRC by an established risk score system and were subsequently recommended for colonoscopy. Participation rates and detection of colorectal neoplasms in this programme were reported and their associated factors were explored.
RESULTS: 25 593 participants undertook colonoscopy as recommended, with participation rate of 14.0%. High level of education, history of faecal occult blood test, family history of CRC and history of colonic polyp were found to be associated with the participation in colonoscopy screening. Overall, 65 CRC (0.25%), 785 advanced adenomas (3.07%), 2091 non-advanced adenomas (8.17%) and 1107 hyperplastic polyps (4.33%) were detected. Detection rates of colorectal neoplasms increased with age and were higher for men. More advanced neoplasms were diagnosed in the distal colon/rectum (65.2%). Several factors including age, sex, family history of CRC, dietary intake of processed meat and smoking were identified to be associated with the presence of colorectal neoplasms.
CONCLUSION: The diagnostic yield was not optimal using colonoscopy screening in high-risk populations given the relatively low participation rate. Our findings will provide important references for designing effective population-based CRC screening strategies in the future. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer epidemiology; colonoscopy; colorectal adenomas; colorectal cancer; colorectal cancer screening

Mesh:

Year:  2018        PMID: 30377193     DOI: 10.1136/gutjnl-2018-317124

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  64 in total

1.  Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.

Authors:  Jie Lin; Lijing Zhang; Mengshi Chen; Juan Chen; Yijuan Wu; Tao Wang; Yan Lu; Zhaofen Ba; Xiaowei Cheng; Rongrong Xu; Tian Tian; Aijuan Sun; Tiantian Zhang; Minghong Chen
Journal:  Int J Colorectal Dis       Date:  2022-05-02       Impact factor: 2.571

2.  The predictive value of routine laboratory tests for colorectal polyps: a retrospective study.

Authors:  Xinyi Feng; Xiuping Jiao; Yemin Xu; Xi Xu; Yan Zhu; Qiang She; Yaoyao Li; Guiqing Li; Jian Wu; Weiming Xiao; Yanbing Ding; Bin Deng
Journal:  J Gastrointest Oncol       Date:  2022-02

3.  Features of colorectal cancer in China stratified by anatomic sites: A hospital-based study conducted in university-affiliated hospitals from 2014 to 2018.

Authors:  Ruize Qu; Yanpeng Ma; Liyuan Tao; Xiaoyuan Bao; Xin Zhou; Bingyan Wang; Fei Li; Siyi Lu; Lin Tuo; Siyan Zhan; Zhipeng Zhang; Wei Fu
Journal:  Chin J Cancer Res       Date:  2021-08-31       Impact factor: 5.087

4.  SNORD15B and SNORA5C: Novel Diagnostic and Prognostic Biomarkers for Colorectal Cancer.

Authors:  Liping Shen; Wenqing Lu; Yujv Huang; Junyan He; Qi Wang; Xiaofei Zheng; Zhidong Wang
Journal:  Biomed Res Int       Date:  2022-05-09       Impact factor: 3.246

5.  Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study.

Authors:  Mingqing Zhang; Lizhong Zhao; Yongdan Zhang; Haoren Jing; Lianbo Wei; Zhixuan Li; Haixiang Zhang; Yong Zhang; Siwei Zhu; Shiwu Zhang; Xipeng Zhang
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

6.  Assessing Individual Risk for High-Risk Early Colorectal Neoplasm for Pre-Selection of Screening in Shanghai, China: A Population-Based Nested Case-Control Study.

Authors:  Jie Shen; Yiling Wu; Xiaoshuang Feng; Fei Liang; Miao Mo; Binxin Cai; Changming Zhou; Zezhou Wang; Meiying Zhu; Guoxiang Cai; Ying Zheng
Journal:  Cancer Manag Res       Date:  2021-05-12       Impact factor: 3.989

7.  Prevalence and Progression of Incidental Terminal Ileitis on Non-diagnostic Colonoscopy: A Systematic Review and Meta-analysis.

Authors:  Manasi Agrawal; Mario Bento- Miranda; Samantha Walsh; Neeraj Narula; Jean-Frederic Colombel; Ryan C Ungaro
Journal:  J Crohns Colitis       Date:  2021-09-25       Impact factor: 9.071

8.  NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity.

Authors:  Batuer Aikemu; Yanfei Shao; Guang Yang; Junjun Ma; Sen Zhang; Xiao Yang; Hiju Hong; Galiya Yesseyeva; Ling Huang; Hongtao Jia; Chenxing Wang; Lu Zang; Jing Sun; Minhua Zheng
Journal:  Int J Biol Sci       Date:  2021-04-17       Impact factor: 6.580

9.  Feasibility of Methylated CLIP4 in Stool for Early Detection of Colorectal Cancer: A Training Study in Chinese Population.

Authors:  Yang Cao; Guodong Zhao; Yaping Cao; Zhiliang Chen; Xiaoyu Liu; Mufa Yuan; Jun Yang; Xiaomei Wang; Yong Ma; Zhaocheng Liu; Shangmin Xiong; Minxue Zheng; Sujuan Fei
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

10.  Incidence and risk factors of colorectal delayed post-polypectomy bleeding in patients taking antithrombotics.

Authors:  Zhen Yan; Feng Gao; Jiang Xie; Jie Zhang
Journal:  J Dig Dis       Date:  2021-08       Impact factor: 3.366

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.